Today’s AI Top Pick: TMDX

7/7/2026 · Highly Shorted Turnaround Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Highly Shorted Turnaround Deep RotationTMDXBUY NOW8.7 / 107/7/2026

TransMedics (TMDX) is the cleanest setup on the board because it's the only name where a top-tier fundamental profile (fundamental_score 6.75, PE 16.35, fwdPe 21.69, ROE 45.22%, profit margin 27.04%, salesYoY 30.24%, EPS next-year +70.83%, recom 1.64) is confirmed by all four timeframes pointing higher with meaningful magnitude and — crucially — the stock is NOT extended. Position in the 21-bar range is 44.66% on the 4h, 38.88% on the daily, and just 9.79% on the weekly, with a -50.96% weekly drawdown from the 21-bar high. That's a deep-rotation setup that hasn't yet done the mean-reversion move. Forecasts line up across horizons: 1h fc_long +82.42%, 4h fc_mid +65.75% / fc_long +124.16%, 1d fc_short +41.16% / fc_mid +66% / fc_long +55.3%, and 1wk fc_mid +28.57%. Near-term_bullish is 1.0 and bullish_prob is 1.0. Unlike PSIX (which has better fundamentals but 1wk fc_mid -51.99% and fc_long -62.72% — a trap), TMDX shows no timeframe disagreement. Unlike BYRN or REAX, it isn't pinned at 100% of range asking to be chased. Recent headlines reinforce entry: an analyst reiterated a 77% upside call (7/1), Motley Fool tagged it as a growth stock "to buy on the dip" (7/2), and a 10-year bull piece dropped 7/3 — no dilution, no guidance cut, no short-seller report. Combine positive catalysts with reasonable valuation (fwdPe ~21 on 70%+ EPS growth = PEG well under 1), and TMDX pays you to wait through downside because the fundamentals justify the multiple even if the forecasts miss. Today is the entry because the 1h and 4h are still in the lower half of their range but the daily short-horizon forecast has already turned aggressively positive (+41%). Waiting risks chasing after the daily mean-reversion completes. Size in now, add on any dip toward the 4h drawdown floor.

Entry zone

$68.50 – $72.50 (starter around $71.23 spot; add zone $68-69 near 4h dd floor)

Stop loss

$62.50 (below the weekly 21-bar low structure; ~12% risk)

First target

$88 (roughly aligns with 1d fc_short +41% and 4h fc_mid trajectory)

Longer target

$115-120 (aligns with 4h fc_long +124%, 1d fc_mid +66%, and analyst 77% upside)

Risks

Short float 23.02% is elevated — squeezes cut both ways; a failed bounce accelerates downside
Debt/Equity 1.75 combined with -44.86% 1Y performance means any organ-transport volume miss re-rates the multiple hard
Weekly chart still in a downtrend (recent_21bar_pct -46.94%, pos_in_range 9.79%) — bottoming, not bottomed
Healthcare/med-device single-product concentration risk (OCS platform); competitive entrants or reimbursement headline would break the thesis
1h short-term forecast is only +1.79% — no immediate momentum kicker, so a shakeout to $67-68 is very possible before the run

Honorable mentions

WIXMulti-TF alignment is arguably even better (1d fc_short +85.59%, fc_mid +111%, 4h fc_mid +86%, near_term_bullish 1.0), and 1wk pos_in_range 15.7% means not chasing. Held back to #2 by weaker fundamental_score (4.5), recom 2.0 (worst in top tier), and JPMorgan just cut target to $62.

MNDYQ1 beat + AI revenue + buyback catalyst is live, 1d fc_mid +82% and 1wk fc_mid +188%, fwdPe 15.3 on 21% EPS growth. Ranks below TMDX because 1h/4h short-horizon forecasts are red (-8.93%, -1.82%) and it's at 87-100% of range on shorter TFs — better as a pullback buy than a chase.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	TMDX	BUY NOW	8.7	Best fundamentals + all-TF forecast agreement + mid-range positioning + positive news — the cleanest setup here.
2	WIX	BUY NOW	7.8	Massive 1d/1wk forecasts (+85% / +217% mid) with 1wk pos 15.7% — great tape, just weaker analyst support.
3	MNDY	BUY PULLBACK	7.5	Q1 beat catalyst and huge 1wk fc_mid +188%, but short TFs already extended — buy the dip to $78.
4	KVYO	BUY PULLBACK	7.0	AI launch catalyst live, recom 1.17, 1d fc_mid +42%, but all short TFs at 100% of range — wait for reset.
5	BYRN	BUY PULLBACK	6.8	EPS next-year +462%, 1d fc_mid +119%, but 1h already rolling (-5%) and weekly drawdown steep.
6	PSIX	WAIT	6.3	Best fundamentals (PE 8, ROE 76%) but 1wk fc_mid -52%/fc_long -63% is a major red flag — screen passes, tape doesn't.
7	CWH	BUY PULLBACK	6.1	1d fc_short +47% / 1wk fc_mid +177%, but analyst target cuts and negative Seeking Alpha coverage cap conviction.
8	CELH	WAIT	6.0	salesYoY +123% is nice but near_term_bullish 0.2, PE 79, 1h/4h forecasts negative — no urgency.
9	FIP	BUY PULLBACK	5.9	Jones Trading initiated Buy $8.75, 1d fc_short +21%, but weekly forecast tepid (-1% to +19%).
10	MVST	BUY PULLBACK	5.7	1d fc_mid +123% / 4h fc_long +234%, but governance investigation overhang from June is unresolved.
11	REAX	WAIT	5.6	1d fc_mid +66% but at 100% of range on three TFs (RSI 70.85) — chase risk high.
12	WING	WAIT	5.4	Fundamentals decent (opMargin 28%, grossMargin 82%) but 1h/1wk forecasts negative, no catalyst.
13	AISP	BUY PULLBACK	5.2	Contract wins + 1wk fc_mid +297%, but SeekingAlpha called out dilution risk in June.
14	PDYN	BUY PULLBACK	5.0	Defense contract catalysts and near_term_bullish 1.0, but forecasts modest and P/S 38 is stretched.
15	PROP	AVOID	4.8	D/E 1222 and 1wk fc_short -100% is a screaming warning — leverage plus signal collapse.
16	QXO	WAIT	4.7	TopBuild deal energizing, but near_term_bullish 0, 1h/4h at bottom of range with negative short-term forecasts.
17	CTXR	AVOID	4.5	Weekly fc_mid +2217% is a fantasy print on a $17M-cap penny — treat as lottery ticket, not investment.
18	AIM	AVOID	4.2	1wk fc +12000% is a signal artifact; $8M cap, profit margin -14000%, DURIPANC readout not until Dec 2026.
19	MBRX	AVOID	3.8	Trial data missed significance June 30, stock dropped 25% — thesis broken regardless of forecast.
20	FLWS	WAIT	3.8	salesYoY -9.5%, no catalyst, multiple bearish StockStory pieces recently.
21	SGRY	AVOID	3.7	1h/4h/1d mid+long forecasts all NEGATIVE (-15% to -25%) at RSI 71.8 — top of range, tape rolling over.
22	SPRY	WAIT	3.5	Russell index removal is a real overhang; forecasts modest (1d fc_mid +27%).
23	HUMA	AVOID	3.2	V012 data split analyst views, profit margin -4840%, weekly forecasts are pure noise.
24	PCT	AVOID	3.1	P/S 141, D/E 99, opMargin -1563% — bullish_prob 0.4 confirms the risk.
25	CRWV	AVOID	3.0	Two negative headlines in 48h (SeekingAlpha downgrade, Cramer reversal), 4h fc_long -5.7%.
26	ASPI	WAIT	3.0	Noble Africa/ENDRA merger is a distraction, 1h fc_long -7.6%, at bottom of range across TFs.
27	PAR	WAIT	2.8	SeekingAlpha called out valuation stretch; no expected_return_pct in data — missing signal.
28	ALKT	AVOID	2.5	Expected return -3.7%, RSI 70, activist headline already in the price.
29	MARA	AVOID	2.3	bullish_prob 0.2, YTD +44% (not a turnaround), 4h fc_long -32.8%.
30	SAFX	AVOID	1.5	expected_return_pct -100, D/E 10.72, tiny $0.15 placement — capital destruction risk.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord